A Phase I-II multicenter, open label trial of H3B-6545, a covalent antagonist of estrogen receptor alpha, in women with locally advanced or metastatic estrogen receptor-positive, HER2 negative breast cancer

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Lone Tree Medical Center
University of Colorado Hospital

Study ID

Protocol Number: 20-2675

More information available at ClinicalTrials.gov: NCT03250676

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers